Dr. Stein on Targeted Therapies for Melanoma

Jennifer A. Stein, MD, PhD
Published: Thursday, Aug 03, 2017



Jennifer A. Stein, MD, PhD, an associate professor of dermatology at NYU Langone Medical Center, discusses targeted therapies for patients with melanoma.

With the BRAF inhibitors, patients can get new skin cancers, particularly squamous cell carcinomas, explains Stein.

Those squamous cell carcinomas are usually seen in older patients, people with fair skin, or those who have had a lot of exposure to the sun, states Stein.
 


Jennifer A. Stein, MD, PhD, an associate professor of dermatology at NYU Langone Medical Center, discusses targeted therapies for patients with melanoma.

With the BRAF inhibitors, patients can get new skin cancers, particularly squamous cell carcinomas, explains Stein.

Those squamous cell carcinomas are usually seen in older patients, people with fair skin, or those who have had a lot of exposure to the sun, states Stein.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: Evolving Roles for Targeted Melanoma Therapies: Assessing Rapid Progress in the Field and Looking Toward Future CombinationsFeb 28, 20191.5
Advances in™ Melanoma: Exploring BRAF/MEK in Adjuvant and Neoadjuvant SettingsSep 28, 20191.5
Publication Bottom Border
Border Publication
x